Nova Eye Medical Limited

ASX:EYE 株式レポート

時価総額:AU$37.8m

Nova Eye Medical 過去の業績

過去 基準チェック /06

Nova Eye Medicalの収益は年間平均-14.9%の割合で減少していますが、 Medical Equipment業界の収益は年間 増加しています。収益は年間8.3% 7.6%割合で 増加しています。

主要情報

-14.9%

収益成長率

-9.8%

EPS成長率

Medical Equipment 業界の成長5.8%
収益成長率7.6%
株主資本利益率-41.2%
ネット・マージン-37.7%
前回の決算情報30 Jun 2024

最近の業績更新

Recent updates

Nova Eye Medical Limited (ASX:EYE) Might Not Be As Mispriced As It Looks After Plunging 26%

Sep 22
Nova Eye Medical Limited (ASX:EYE) Might Not Be As Mispriced As It Looks After Plunging 26%

Take Care Before Diving Into The Deep End On Nova Eye Medical Limited (ASX:EYE)

Aug 06
Take Care Before Diving Into The Deep End On Nova Eye Medical Limited (ASX:EYE)

Nova Eye Medical Limited (ASX:EYE) Soars 29% But It's A Story Of Risk Vs Reward

Apr 18
Nova Eye Medical Limited (ASX:EYE) Soars 29% But It's A Story Of Risk Vs Reward

Is There An Opportunity With Nova Eye Medical Limited's (ASX:EYE) 43% Undervaluation?

Mar 26
Is There An Opportunity With Nova Eye Medical Limited's (ASX:EYE) 43% Undervaluation?

News Flash: Analysts Just Made A Captivating Upgrade To Their Nova Eye Medical Limited (ASX:EYE) Forecasts

Jan 19
News Flash: Analysts Just Made A Captivating Upgrade To Their Nova Eye Medical Limited (ASX:EYE) Forecasts

Further Upside For Nova Eye Medical Limited (ASX:EYE) Shares Could Introduce Price Risks After 38% Bounce

Dec 27
Further Upside For Nova Eye Medical Limited (ASX:EYE) Shares Could Introduce Price Risks After 38% Bounce

We're Not Very Worried About Nova Eye Medical's (ASX:EYE) Cash Burn Rate

Sep 03
We're Not Very Worried About Nova Eye Medical's (ASX:EYE) Cash Burn Rate

Improved Revenues Required Before Nova Eye Medical Limited (ASX:EYE) Stock's 43% Jump Looks Justified

Apr 17
Improved Revenues Required Before Nova Eye Medical Limited (ASX:EYE) Stock's 43% Jump Looks Justified

Is Nova Eye Medical (ASX:EYE) In A Good Position To Invest In Growth?

Dec 16
Is Nova Eye Medical (ASX:EYE) In A Good Position To Invest In Growth?

We Think Nova Eye Medical (ASX:EYE) Needs To Drive Business Growth Carefully

Aug 27
We Think Nova Eye Medical (ASX:EYE) Needs To Drive Business Growth Carefully

収支内訳

Nova Eye Medical の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

ASX:EYE 収益、費用、利益 ( )AUD Millions
日付収益収益G+A経費研究開発費
30 Jun 2423-9230
31 Mar 2421-12230
31 Dec 2319-14220
30 Sep 2318-15220
30 Jun 2317-15220
31 Mar 2316-13210
31 Dec 2215-11210
30 Sep 2214-9190
30 Jun 2213-7170
31 Mar 2213-7160
31 Dec 2113-6150
30 Sep 2113-5140
30 Jun 2113-4130
31 Dec 2012-9120
30 Sep 2013-10130
30 Jun 2013-10140
31 Dec 1916-6160
30 Sep 1916-6170
30 Jun 1916-7180
31 Mar 1948-7341
31 Dec 1849-6341
30 Sep 1864-6371
30 Jun 1879-5411
31 Mar 1877-5361
31 Dec 1775-5321
30 Sep 1773-3311
30 Jun 1772-1291
31 Mar 17721281
31 Dec 16733271
30 Sep 16733261
30 Jun 16733261
31 Mar 16703241
31 Dec 15672221
30 Sep 15652221
30 Jun 15632211
31 Mar 15611201
31 Dec 14591191
30 Sep 14571181
30 Jun 14541171
31 Mar 14510161
31 Dec 1347-1151

質の高い収益: EYEは現在利益が出ていません。

利益率の向上: EYEは現在利益が出ていません。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: EYEは利益が出ておらず、過去 5 年間で損失は年間14.9%の割合で増加しています。

成長の加速: EYEの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: EYEは利益が出ていないため、過去 1 年間の収益成長をMedical Equipment業界 ( 18.7% ) と比較することは困難です。


株主資本利益率

高いROE: EYEは現在利益が出ていないため、自己資本利益率 ( -41.21% ) はマイナスです。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘